An update on nonsteroidal anti-inflammatory drugs and gastrointestinal risk
Recommendations for the prevention of nonsteroidal anti-inflammatory drug (NSAID)-related gastrointestinal ulceration and cardiovascular (CV) complications were recently made available through an initiative designed in collaboration with leading specialists in South Africa. The prevention of CV comp...
Saved in:
Main Author: | Jacky van Schoor |
---|---|
Format: | Article |
Language: | English |
Published: |
AOSIS
2014-07-01
|
Series: | South African Family Practice |
Subjects: | |
Online Access: | https://safpj.co.za/index.php/safpj/article/view/4191 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Cardiovascular effects and the use of nonsteroidal anti-inflammatory drugs
by: N. Schellack
Published: (2014-02-01) -
ASSESSMENT OF RISK FOR GASTROINTESTINAL AND CARDIOVASCULAR COMPLICATIONS ASSOCIATED WITH THE USE OF NONSTEROIDAL ANTI-INFLAMMATORY DRUGS IN THE CIS POPULATION: PRELIMINARY DATA OF THE CORONA-2 EPIDEMIOLOGICAL SURVEY
by: A. E. Karateev, et al.
Published: (2014-12-01) -
BIOPHARMACEUTICAL PROPERTIES OF THE NONSTEROIDAL ANTI-INFLAMMATORY DRUGS
by: Y. I. Kulinich
Published: (2012-03-01) -
RATIONAL USE OF NONSTEROIDAL ANTI-INFLAMMATORY DRUGS. CLINICAL GUIDELINES
by: A. E. Karateev, et al.
Published: (2018-05-01) -
What is new? An overview of the 2016 international publications on the efficacy and safety of nonsteroidal anti-inflammatory drugs
by: A. E. Karateev
Published: (2017-03-01)